Company / R&D Expense
Thermo Fisher Scientific R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$1.4B
FY2025
5-year range
$1.0B / $1.4B
FY2021-FY2025
Trend
+0.5%
vs FY2024
Sector context
#6 of 110
Health Care
What the data says
Among 110 Health Care companies, Thermo Fisher Scientific is in the top 5% for r&d expense. R&D Expense has fluctuated over the past 10 years, ranging from $754M in FY2016 to $1.4B in FY2023.
Based on SEC 10-K filings.
$1.4B in FY2025 with a 5-year CAGR of +3.4%. Top quartile in the Health Care sector.
Remained stable around $1.4B over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +5.8%
- 5-Year CAGR
- +3.4%
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 110This company $1.4B Sector average $298.2M
▼
+368.5% above sector average
Key checks
Key Insights
- 5-year CAGR of +3.4%, indicating consistent growth.
- In FY2025, r&d expense increased 0.5% year-over-year.
- Ranks #6 out of 110 companies in the Health Care sector.
- Peak r&d expense was recorded in FY2023.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.4B | +0.5% |
| FY2024 | $1.4B | -1.1% |
| FY2023 | $1.4B | +19.1% |
| FY2022 | $1.2B | +17.7% |
| FY2021 | $1.0B | -15.1% |
| FY2020 | $1.2B | +17.7% |
| FY2019 | $1.0B | +3.7% |
| FY2018 | $967.0M | +9.0% |
| FY2017 | $887.0M | +17.6% |
| FY2016 | $754.0M | +9.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026